Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Dominovas Energy Corporation (DNRG) Announces Agreement in Principle to Acquire Guatemala-Based Grupo Trébol

Before the opening bell, Dominovas Energy Corporation (OTCQB: DNRG) announced an agreement of principle terms to acquire Grupo Trébol Holding, a private global energy solutions company based in Guatemala City, Guatemala, with operations and strategic partnerships throughout Central and South America. According to the news release, Grupo Trébol operates with “minimal debt and more than […]

Nutra Pharma Corporation (NPHC) Initiates 2016 Growth Strategy with Key Addition to Management Team

Before the opening bell, Nutra Pharma Corporation (OTCQB: NPHC) announced a key expansion of personnel, naming Thomas W. Northrop as its senior commercial development officer. Northrop is a Fellow of the American College of Healthcare Executives with experience leading hospitals, healthcare networks and physician groups in several regions of the country. He is also a […]

Implant Sciences Corporation (IMSC) Well Positioned to Capitalize on Growth of Global Explosives Trace Detection Market

Implant Sciences Corporation (OTCQB: IMSC) is a leader in the development and manufacture of advanced detection technologies designed to counter and eliminate the ever-evolving threats presented by explosives and drugs. The company’s explosives trace detection (ETD) and drugs trace detection solutions target a wide variety of vital security applications – including aviation, transportation, customs, air […]

Dominovas Energy Corp. (DNRG) Looks to become Global Leader in Solid Oxide Fuel Cell Development

The Dominovas Energy Corporation (OTCQB: DNRG) is at the forefront of the alternative energy industry with its innovative RUBICON™ solid oxide fuel cell (SOFC). Fuel cells are an efficient, combustion-less, reliable, and virtually pollution-free energy source that provide electricity to power a wide array of applications, including buildings (manufacturing facilities, hotels and hospitals), primary power […]

Moxian, Inc. (MOXC) Promotes Precision Marketing

Moxian, Inc. (OTCQB: MOXC) specializes in precision marketing. For six years, the company has fixed its attention on enabling business owners to engage in high-level, targeted marketing. How? Moxian has combined a customer relations management tool with data analysis capabilities to offer a comprehensive solution — an online-to-offline platform — that incorporates social media and […]

Alternet Systems, Inc. (ALYI): Bridging the Gap between Merchants and Consumers via Payment Technology Solutions

Smartphones are attached to everyone’s hip in today’s world. Mobile payment solutions, such as PayPal (NASDAQ: PYPL) and Apple Pay, are being integrated into every new technology that emerges. When you launch an online store, the most important function of the website is the payment option. Today’s world moves at light speed and consumers demand […]

OncBioMune Pharmaceuticals, Inc. (OBMP) Preparing to Commence Phase II Clinical Study of ProscaVax™ Cancer Vaccine

OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products. The company’s lead product candidate, ProscaVax™, is a novel prostate cancer vaccine that’s scheduled to commence a phase II clinical trial in the coming weeks after recording promising results in its phase I clinical trial, which […]

 

From Our Blog

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Developing Two-Pronged Attack on Brain Disorders Affecting Millions

July 21, 2026

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Neurological disorders affect hundreds of millions of people worldwide, and for many of those patients, existing treatments fall far short. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM), a biopharmaceutical company, is working to change that, with a pipeline targeting two significant […]

Rotate your device 90° to view site.